메뉴 건너뛰기




Volumn 37, Issue 4, 2014, Pages 193-203

Complementation of antigen-presenting cells to generate t lymphocytes with broad target specificity

Author keywords

Cancer; Immunotherapy; Lymphoma; Nasopharyngeal carcinoma; T cell therapy

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; CD137 LIGAND; CD28 ANTIGEN; CD83 ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; L SELECTIN; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; EBV-ENCODED NUCLEAR ANTIGEN 1; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; MATRIX PROTEIN; PEPTIDE; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; VIRUS ANTIGEN;

EID: 84897974244     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0000000000000014     Document Type: Article
Times cited : (41)

References (30)
  • 1
    • 35549008976 scopus 로고    scopus 로고
    • Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
    • Bollard CM, Gottschalk S, Leen AM, et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood. 2007;110:2838-2845.
    • (2007) Blood. , vol.110 , pp. 2838-2845
    • Bollard, C.M.1    Gottschalk, S.2    Leen, A.M.3
  • 2
    • 84859492195 scopus 로고    scopus 로고
    • A phase II study evaluating the safety and efficacy of an adenovirus-DeltaLMP1- LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
    • Chia WK, Wang WW, Teo M, et al. A phase II study evaluating the safety and efficacy of an adenovirus-DeltaLMP1- LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma. Ann Oncol. 2012;23:997-1005.
    • (2012) Ann Oncol. , pp. 997-1005
    • Chia, W.K.1    Wang, W.W.2    Teo, M.3
  • 3
    • 83755229580 scopus 로고    scopus 로고
    • Feasibility and safety of adoptive immunotherapy with ex vivo-generatedautologous, cytotoxic T lymphocytes in patients with solid tumor
    • Montagna D, Turin I, Schiavo R, et al. Feasibility and safety of adoptive immunotherapy with ex vivo-generatedautologous, cytotoxic T lymphocytes in patients with solid tumor. Cytotherapy. 2012;14:80-90.
    • (2012) Cytotherapy. , pp. 80-90
    • Montagna, D.1    Turin, I.2    Schiavo, R.3
  • 4
    • 84864551731 scopus 로고    scopus 로고
    • Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: A pilot study
    • Meij P, Jedema I, van der Hoorn MA, et al. Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study. Haematologica. 2012;97: 1205-1208.
    • (2012) Haematologica. , vol.97 , pp. 1205-1208
    • Meij, P.1    Jedema, I.2    Van Der Hoorn, M.A.3
  • 5
    • 84875975917 scopus 로고    scopus 로고
    • Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients
    • Chapuis AG, Ragnarsson GB, Nguyen HN, et al. Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients. Sci Translational Med. 2013;5:174ra127.
    • (2013) Sci Translational Med. , vol.5
    • Chapuis, A.G.1    Ragnarsson, G.B.2    Nguyen, H.N.3
  • 6
    • 0035452356 scopus 로고    scopus 로고
    • Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma
    • Gahn B, Siller-Lopez F, Pirooz AD, et al. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma. Int J Cancer. 2001;93:706-713.
    • (2001) Int J Cancer. , vol.93 , pp. 706-713
    • Gahn, B.1    Siller-Lopez, F.2    Pirooz, A.D.3
  • 7
    • 80052171650 scopus 로고    scopus 로고
    • Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
    • Lacey SF, La Rosa C, Kaltcheva T, et al. Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice. Blood. 2011;118:2159-2169.
    • (2011) Blood. , vol.118 , pp. 2159-2169
    • Lacey, S.F.1    La Rosa, C.2    Kaltcheva, T.3
  • 8
    • 13544273197 scopus 로고    scopus 로고
    • Enhanced antilymphoma efficacy of CD19-redirected influenza MP1- specific CTLs by cotransfer of T cells modified to present influenza MP1
    • Cooper LJ, Al-Kadhimi Z, Serrano LM, et al. Enhanced antilymphoma efficacy of CD19-redirected influenza MP1- specific CTLs by cotransfer of T cells modified to present influenza MP1. Blood. 2005;105:1622-1631.
    • (2005) Blood. , vol.105 , pp. 1622-1631
    • Cooper, L.J.1    Al-Kadhimi, Z.2    Serrano, L.M.3
  • 9
    • 34250896852 scopus 로고    scopus 로고
    • Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12
    • Foster AE, Leen AM, Lee T, et al. Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12. J Immunother. 2007;30:506-516.
    • (2007) J Immunother. , vol.30 , pp. 506-516
    • Foster, A.E.1    Leen, A.M.2    Lee, T.3
  • 10
    • 34247212403 scopus 로고    scopus 로고
    • Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
    • Suhoski MM, Golovina TN, Aqui NA, et al. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther. 2007;15:981-988.
    • (2007) Mol Ther. , vol.15 , pp. 981-988
    • Suhoski, M.M.1    Golovina, T.N.2    Aqui, N.A.3
  • 11
    • 19944426160 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte therapy for Epstein-Barr virus+Hodgkin's disease
    • Bollard CM, Aguilar L, Straathof KC, et al. Cytotoxic T lymphocyte therapy for Epstein-Barr virus+Hodgkin's disease. J Exp Med. 2004;200:1623-1633.
    • (2004) J Exp Med. , vol.200 , pp. 1623-1633
    • Bollard, C.M.1    Aguilar, L.2    Straathof, K.C.3
  • 12
    • 78149280601 scopus 로고    scopus 로고
    • Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma
    • Louis CU, Straathof K, Bollard CM, et al. Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother. 2010;33:983-990.
    • (2010) J Immunother. , vol.33 , pp. 983-990
    • Louis, C.U.1    Straathof, K.2    Bollard, C.M.3
  • 13
    • 0029082690 scopus 로고
    • Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease
    • Smith CA, Ng CY, Heslop HE, et al. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J Hematother. 1995;4:73-79.
    • (1995) J Hematother. , vol.4 , pp. 73-79
    • Smith, C.A.1    Ng, C.Y.2    Heslop, H.E.3
  • 14
    • 84864547457 scopus 로고    scopus 로고
    • Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections
    • Gerdemann U, Keirnan JM, Katari UL, et al. Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections. Mol Ther. 2012; 20:1622-1632.
    • (2012) Mol Ther. , vol.20 , pp. 1622-1632
    • Gerdemann, U.1    Keirnan, J.M.2    Katari, U.L.3
  • 15
    • 79954475216 scopus 로고    scopus 로고
    • Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma
    • Bollard CM, Gottschalk S, Helen Huls M, et al. Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma. Cytotherapy. 2011;13:518-522.
    • (2011) Cytotherapy. , vol.13 , pp. 518-522
    • Bollard, C.M.1    Gottschalk, S.2    Helen Huls, M.3
  • 16
    • 0037500890 scopus 로고    scopus 로고
    • Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy
    • Sili U, Huls MH, Davis AR, et al. Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy. J Immunother. 2003;26:241-256.
    • (2003) J Immunother. , vol.26 , pp. 241-256
    • Sili, U.1    Huls, M.H.2    Davis, A.R.3
  • 17
    • 76949100884 scopus 로고    scopus 로고
    • Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex)
    • Vera JF, Brenner LJ, Gerdemann U, et al. Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex). J Immunother. 2010;33:305-315.
    • (2010) J Immunother. , vol.33 , pp. 305-315
    • Vera, J.F.1    Brenner, L.J.2    Gerdemann, U.3
  • 18
    • 0036812719 scopus 로고    scopus 로고
    • Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes
    • Melief CJ, Van Der Burg SH, Toes RE, et al. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol Rev. 2002;188:177-182.
    • (2002) Immunol Rev. , vol.188 , pp. 177-182
    • Melief, C.J.1    Van Der Burg, S.H.2    Toes, R.E.3
  • 19
    • 80052871458 scopus 로고    scopus 로고
    • Comparison of two CD40- ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia
    • Okur FV, Yvon E, Biagi E, et al. Comparison of two CD40- ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia. Cytotherapy. 2011;13:1128-1139.
    • (2011) Cytotherapy. , vol.13 , pp. 1128-1139
    • Okur, F.V.1    Yvon, E.2    Biagi, E.3
  • 20
    • 84871294655 scopus 로고    scopus 로고
    • Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC
    • Decker WK, Shah N, Xing D, et al. Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC. PloS one. 2012;7:e51390.
    • (2012) PloS One. , vol.7
    • Decker, W.K.1    Shah, N.2    Xing, D.3
  • 21
    • 33749514632 scopus 로고    scopus 로고
    • Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
    • Leen AM, Myers GD, Sili U, et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006;12:1160-1166.
    • (2006) Nat Med. , vol.12 , pp. 1160-1166
    • Leen, A.M.1    Myers, G.D.2    Sili, U.3
  • 22
    • 79954600403 scopus 로고    scopus 로고
    • Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in highrisk patients
    • Reddy N, Rezvani K, Barrett AJ, et al. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in highrisk patients. Biol Blood Marrow Transplant. 2011;17:591-597.
    • (2011) Biol Blood Marrow Transplant. , vol.17 , pp. 591-597
    • Reddy, N.1    Rezvani, K.2    Barrett, A.J.3
  • 23
    • 0034781060 scopus 로고    scopus 로고
    • Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay
    • Becker C, Pohla H, Frankenberger B, et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat Med. 2001;7:1159-1162.
    • (2001) Nat Med. , vol.7 , pp. 1159-1162
    • Becker, C.1    Pohla, H.2    Frankenberger, B.3
  • 24
    • 33847350843 scopus 로고    scopus 로고
    • Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virusderived antigens
    • Neudorfer J, Schmidt B, Huster KM, et al. Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virusderived antigens. J Immunol Meth. 2007;320:119-131.
    • (2007) J Immunol Meth. , vol.320 , pp. 119-131
    • Neudorfer, J.1    Schmidt, B.2    Huster, K.M.3
  • 25
    • 79952470341 scopus 로고    scopus 로고
    • Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirusspecific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
    • Schmitt A, Tonn T, Busch DH, et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirusspecific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion. 2011;51:591-599.
    • (2011) Transfusion. , vol.51 , pp. 591-599
    • Schmitt, A.1    Tonn, T.2    Busch, D.H.3
  • 26
    • 80052845092 scopus 로고    scopus 로고
    • Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes
    • Weng J, Cha SC, Matsueda S, et al. Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes. Clinical Cancer Res. 2011;17:5945-5952.
    • (2011) Clinical Cancer Res. , vol.17 , pp. 5945-5952
    • Weng, J.1    Cha, S.C.2    Matsueda, S.3
  • 27
    • 84866501841 scopus 로고    scopus 로고
    • Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
    • Lapteva N, Durett AG, Sun J, et al. Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy. 2012;14:1131-1143.
    • (2012) Cytotherapy. , vol.14 , pp. 1131-1143
    • Lapteva, N.1    Durett, A.G.2    Sun, J.3
  • 28
    • 79961133788 scopus 로고    scopus 로고
    • Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
    • Ye Q, Loisiou M, Levine BL, et al. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J Transl Med. 2011;9:131.
    • (2011) J Transl Med. , vol.9 , pp. 131
    • Ye, Q.1    Loisiou, M.2    Levine, B.L.3
  • 29
    • 70350726110 scopus 로고    scopus 로고
    • Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
    • Milone MC, Fish JD, Carpenito C, et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol Ther. 2009;17:1453-1464.
    • (2009) Mol Ther. , vol.17 , pp. 1453-1464
    • Milone, M.C.1    Fish, J.D.2    Carpenito, C.3
  • 30
    • 79956149133 scopus 로고    scopus 로고
    • Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
    • Singh H, Figliola MJ, Dawson MJ, et al. Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer Res. 2011;71:3516-3527.
    • (2011) Cancer Res. , vol.71 , pp. 3516-3527
    • Singh, H.1    Figliola, M.J.2    Dawson, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.